Vera Therapeutics Ownership | Who Owns Vera Therapeutics?

Vera Therapeutics Ownership Summary

Vera Therapeutics is owned by 100.14% institutional investors, 3.96% insiders. Avoro capital advisors is the largest institutional shareholder, holding 9.88% of VERA shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 2.45% of its assets in Vera Therapeutics shares.

VERA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Vera Therapeutics	100.14%	3.96%	-4.11%
Sector	Healthcare Stocks	486.50%	11.08%	-397.59%
Industry	Biotech Stocks	304.14%	11.08%	-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Avoro capital advisors	6.30M	9.88%	$148.43M
Price t rowe associates inc /md/	4.38M	7.97%	$185.11M
Blackrock	3.34M	6.55%	$120.76M
Blackrock funding, inc. /de	4.17M	6.53%	$98.14M
Fmr	3.05M	5.56%	$129.12M
Vanguard group	2.95M	5.37%	$124.74M
Kynam capital management, lp	3.43M	5.37%	$80.74M
Deerfield management company, l.p. (series c)	3.35M	5.25%	$78.88M
Vestal point capital, lp	3.10M	4.86%	$73.04M
Sofinnova investments	2.79M	4.38%	$65.83M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Kynam capital management, lp	3.43M	8.69%	$80.74M
Commodore capital lp	1.96M	6.07%	$82.83M
Eversept partners, lp	2.38M	5.16%	$56.14M
Portman	32.80K	4.48%	$1.19M
Sofinnova investments	2.79M	4.03%	$65.83M
Vestal point capital, lp	3.10M	3.85%	$73.04M
First turn management	464.81K	3.52%	$19.66M
Avoro capital advisors	6.30M	2.60%	$148.43M
Integral health asset management	1.15M	2.48%	$27.09M
Bioimpact capital	563.08K	2.30%	$13.27M

Top Buyers

Holder	Shares	% Assets	Change
Deerfield management company, l.p. (series c)	3.35M	1.43%	2.30M
Tang capital management	1.35M	1.61%	1.20M
Kynam capital management, lp	3.43M	8.69%	1.03M
Vestal point capital, lp	3.10M	3.85%	600.00K
Avoro capital advisors	6.30M	2.60%	598.10K

Top Sellers

Holder	Shares	% Assets	Change
Holocene advisors, lp	-	-	-2.20M
T. rowe price investment management	-	-	-1.68M
Paradigm biocapital advisors lp	-	-	-1.44M
Morgan stanley	305.44K	0.00%	-1.23M
Samlyn capital	-	-	-978.42K

New Positions

Holder	Shares	% Assets	Change	Value
Hudson bay capital management lp	298.98K	0.02%	298.98K	$7.04M
Voloridge investment management	155.83K	0.01%	155.83K	$3.67M
Avidity partners management lp	100.00K	0.42%	100.00K	$4.23M
Bollard group	64.04K	0.03%	64.04K	$1.51M
Norges bank	48.59K	0.00%	48.59K	$2.05M

Sold Out

Holder	Change
Ifp advisors	-1.00
Parallel advisors	-2.00
Pnc financial services group	-5.00
Coldstream capital management	-6.00
Nelson, van denburg & campbell wealth management group	-7.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	184	0.55%	63,880,155	2.67%	100	1.05%	108	9.09%	47	-4.08%
Mar 31, 2025	186	1.64%	62,983,082	0.11%	98	0.75%	101	-20.47%	50	35.14%
Dec 31, 2024	174	-2.25%	59,594,280	11.34%	108	1.14%	121	26.04%	35	-30.00%
Sep 30, 2024	178	1.71%	53,475,724	0.91%	97	0.90%	96	-6.80%	50	-10.71%
Jun 30, 2024	175	2.94%	52,992,297	3.28%	103	1.03%	103	-17.60%	56	86.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
US Small-Cap Growth II Equity Comp	1.56M	2.45%	-117.37K
T. Rowe Price New Horizons	1.56M	2.45%	-35.82K
Vanguard Total Stock Mkt Idx Inv	1.50M	2.36%	-33.34K
Fidelity Growth Compy Commingled Pl O	1.16M	2.11%	-
Vanguard US Total Market Shares ETF	1.33M	2.09%	-2.90K
iShares Russell 2000 ETF	1.21M	1.90%	-23.00K
Fidelity Growth Compy Commingled Pl S	1.19M	1.86%	1.07K
T. Rowe Price Health Sciences	1.17M	1.83%	29.38K
Fidelity Growth Company Fund	884.00K	1.39%	-
SPDR® S&P Biotech ETF	873.29K	1.37%	21.56K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 24, 2025	ENRIGHT PATRICK G	-	Buy	$605.08K
Jun 24, 2025	ENRIGHT PATRICK G	-	Buy	$302.55K
Jun 23, 2025	ENRIGHT PATRICK G	-	Buy	$1.46M
Jun 23, 2025	ENRIGHT PATRICK G	-	Buy	$2.91M
Feb 21, 2025	Fordyce Marshall	PRESIDENT AND CEO	Sell	$296.03K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	4	-
2025 Q1	-	6
2024 Q4	-	31
2024 Q3	-	21
2024 Q2	-	24

VERA Ownership FAQ

Who Owns Vera Therapeutics?

Vera Therapeutics shareholders are primarily institutional investors at 100.14%, followed by 3.96% insiders and -4.10% retail investors. The average institutional ownership in Vera Therapeutics's industry, Biotech Stocks , is 304.14%, which Vera Therapeutics falls below.

Who owns the most shares of Vera Therapeutics?

Vera Therapeutics’s largest shareholders are Avoro capital advisors (6.3M shares, 9.88%), Price t rowe associates inc /md/ (4.38M shares, 7.97%), and Blackrock (3.34M shares, 6.55%). Together, they hold 24.40% of Vera Therapeutics’s total shares outstanding.

Does Blackrock own Vera Therapeutics?

Yes, BlackRock owns 6.55% of Vera Therapeutics, totaling 3.34M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 120.76M$. In the last quarter, BlackRock increased its holdings by 18.71K shares, a 0.56% change.

Who is Vera Therapeutics’s biggest shareholder by percentage of total assets invested?

Kynam capital management, lp is Vera Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.69% of its assets in 3.43M Vera Therapeutics shares, valued at 80.74M$.

Who is the top mutual fund holder of Vera Therapeutics shares?

US Small-Cap Growth II Equity Comp is the top mutual fund holder of Vera Therapeutics shares, with 2.45% of its total shares outstanding invested in 1.56M Vera Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools